eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
1/2008
vol. 12
 
Share:
Share:
more
 
 
abstract:

Hepatotoxicity during anti-cancer chemotherapy

Magdalena Piątkowska, Monika Pogorzała, Robert Dębski, Jan Styczyński

Współczesna Onkologia (2008) vol. 12; 1 (16–19)
Online publish date: 2008/03/20
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Background: Hepatotoxicity is defined as injury to the liver that is associated with impaired liver function caused by exposure to a drug or another noninfectious agent. It is one of the most frequent direct side effects of chemotherapy. Cytotoxic drugs which cause hepatotoxicity are: methotrexate, mercaptopurine, cytarabine, 5-fluorouracil, L-asparaginase, cyclophosphamide, busulfan, dacarbazine, mitomycin, thioguanine, mitramycin, etoposide, nitrosourea derivatives (carmustine, lomustine), cisplatin; while actinomycin, doxorubicin, vincristine and vinblastine cause liver injury less often.
Objective: Analysis of grade of hepatotoxicity in children treated for neoplastic diseases.
Material and methods: The study group consisted of 237 patients with cancer. Concentration of total serum bilirubin, activity of glutamyl pyruvic transaminase (GPT, AlAT) and glutamyl oxaloacetic transaminase (GOT, AspAT) was analyzed. Common toxicity criteria for adverse events CTCAE v3.0 was used for grading the hepatotoxicity. Results: Biochemical symptoms of hepatotoxicity were observed in 59.4% of children with cancer, including 24.9% of patients with grade III/IV of toxicity, which prevented continuation of chemotherapy. Hepatotoxicity of grade III/IV was most often observed in children treated for acute lymphoblastic leukaemia and non-Hodgkin’s lymphoma, while it was not observed in patients with Hodgkin’s disease, Langerhans cell histiocytosis or chronic myeloid leukaemia.
Conclusions: Hepatotoxicity is a frequent adverse event of chemotherapy in children. Increased activity of glutamyl pyruvic transaminase (GPT, AlAT) is the main biochemical feature of direct liver injury.
keywords:

hepatotoxicity, children, chemotherapy, GOT, GPT, bilirubin, acute lymphoblastic leukaemia

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe